Molecular Mechanisms for Antiviral Activities and HIV-1 Resistance to Allosteric Integrase Inhibitors

Molecular Mechanisms for Antiviral Activities and HIV-1 Resistance to Allosteric Integrase Inhibitors

Bibliographic Details
Main Author:	Hoyte, Ashley Christopher
Language:	English
Published:	The Ohio State University / OhioLINK 2018
Subjects:	Pharmaceuticals Pharmacy Sciences Biochemistry Virology HIV ALLINI MINI Class II mutants Drug resistant mutants HIV inhibitors Gag-Pol T124N
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=osu1543436136541123

Similar Items

Mechanism of action of allosteric HIV-1 integrase inhibitors
by: Slaughter, Alison Paige
Published: (2015)

Mechanistic and Structural Investigations into the Mode of Action of Allosteric HIV-1 Integrase Inhibitors
by: Koneru, Pratibha Chowdary
Published: (2019)

HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
by: Pratibha C Koneru, et al.
Published: (2019-05-01)

Kinetic and thermodynamic characterisation of HIV-protease inhibitors against E35D↑G↑S mutant in the South African HIV-1 subtype C protease
by: Sibusiso Maseko, et al.
Published: (2019-01-01)

HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag
by: Fu-Hsien Yu, et al.
Published: (2020-01-01)

HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity
by: Fu-Hsien Yu, et al.
Published: (2018-04-01)

Chemokines and glycosaminoglycans
by: Amanda E.I. Proudfoot
Published: (2015-05-01)

Reviewing HIV-1 Gag Mutations in Protease Inhibitors Resistance: Insights for Possible Novel Gag Inhibitor Designs
by: Chinh Tran-To Su, et al.
Published: (2019-09-01)

HIV-1 <i>Gag-Pol </i>Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity
by: Anne Kapaata, et al.
Published: (2021-01-01)

Sequential trafficking of Env and Gag to HIV-1 T cell virological synapses revealed by live imaging
by: Lili Wang, et al.
Published: (2019-01-01)

HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study
by: Murrell, Derek E., et al.
Published: (2019)

HIV-1 Maturation: Lessons Learned from Inhibitors
by: Alex B. Kleinpeter, et al.
Published: (2020-08-01)

Pharmacological intervention of HIV-1 maturation
by: Dan Wang, et al.
Published: (2015-11-01)

Biochemical characteristics of functional domains using feline foamy virus integrase mutants
by: Gwi-woong Yoo, et al.
Published: (2013-01-01)

Role of Gag in HIV Resistance to Protease Inhibitors
by: Fabrizio Mammano, et al.
Published: (2010-07-01)

Novel and Potent Small Molecules against Melanoma Harboring BRAF Class I/II/III Mutants for Overcoming Drug Resistance
by: Namkyoung Kim, et al.
Published: (2021-04-01)

HIV Integrase Inhibitor Pharmacogenetics and Clinical Outcomes: An Exploratory Association Study
by: Murrell, Derek E
Published: (2018)

Chaperone mechanism of the HIV-1 Gag and its promotion by the RPL7 host protein
by: Nadeem, Muhammad Faisal
Published: (2019)

Dataset of differentially regulated proteins in HUVECs challenged with wild type and UGM1 mutant Aspergillus fumigatus strains
by: Gabriela Westerlund Peixoto Neves, et al.
Published: (2016-12-01)

HIV-1 Productively Infects and Integrates in Bronchial Epithelial Cells
by: Dinesh Devadoss, et al.
Published: (2021-02-01)

Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
by: Aleksey Viktorovich Kravchenko, et al.
Published: (2010-11-01)

Symposium on HIV Variants and Hepatitis B Surface Antigen Mutants
by: Gerald G. Schochetman, et al.
Published: (2005-10-01)

Cloning, Expression and Purification of a Novel Multi-epitopic HIV-1 Vaccine Candidate: A Preliminary Study on Immunoreactivity
by: Samira Arabi, et al.
Published: (2014-08-01)

Broad-Spectrum Antiviral Activity of an Ankyrin Repeat Protein on Viral Assembly against Chimeric NL4-3 Viruses Carrying Gag/PR Derived from Circulating Strains among Northern Thai Patients
by: Supachai Sakkhachornphop, et al.
Published: (2018-11-01)

The prototype foamy virus protease is active independently of the integrase domain
by: Spannaus Ralf, et al.
Published: (2012-05-01)

Molecular Docking Studies of Marine Diterpenes as Inhibitors of Wild-Type and Mutants HIV-1 Reverse Transcriptase
by: Alessandra M. T. de Souza, et al.
Published: (2013-10-01)

HIV INTEGRASE INHIBITORS: THE BASIS OF EFFECTIVE AND SAFE ANTIRETROVIRAL THERAPY
by: V. I. SHAKHGILDYAN
Published: (2017-05-01)

Insights into the Activity of Second-Generation Maturation Inhibitors against HIV Clade C
by: Dibya Ghimire, et al.
Published: (2020-06-01)

Inhibition of HIV-1 integrase by [alpha]-luffin and RNA interference.
Published: (2005)

Antiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein
by: Nangola Sawitree, et al.
Published: (2012-02-01)

Chemistry and Structure-Activity Relationship of the Styrylquinoline-Type HIV Integrase Inhibitors
by: Didier Desmaële, et al.
Published: (2010-04-01)

Co-evolution of HIV-1 Protease and its Substrates: A Dissertation
by: Kolli, Madhavi
Published: (2009)

Biological and Immunological Characterization of Plant-Produced HIV-1 Gag/dgp41 Virus-Like Particles
Published: (2011)

Characterizing interactions of HIV-1 integrase with viral DNA and the cellular cofactor LEDGF
by: McKee, Christopher J.
Published: (2010)

Genetic mapping and molecular characterization of tbr1 mutant in Arabidopsis thaliana
by: Nita, Ana-Silvia
Published: (2005)

Understanding Prototype Foamy Virus Integrase Site Selection, Activity, and Stability
by: Mackler, Randi Michelle
Published: (2018)

Studies towards the development of novel HIV-1 integrase inhibitors
by: Lee, Yi-Chen
Published: (2010)

Generation of soluble, catalytically active covalent HIV-1 subtype C integrase-DNA complexes to identify novel strand transfer inhibitors
by: Beyleveld, Grant James
Published: (2014)

Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors
by: Rossana Scutari, et al.
Published: (2020-03-01)

Study on suitable analysis method for HIV-1 non-catalytic integrase inhibitor
by: Ki Hoon Park, et al.
Published: (2021-01-01)